» Authors » Silvia Scaranzin

Silvia Scaranzin

Explore the profile of Silvia Scaranzin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 115
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Masciocchi S, Businaro P, Greco G, Scaranzin S, Malvaso A, Morandi C, et al.
Neurol Neuroimmunol Neuroinflamm . 2025 Jan; 12(2):e200359. PMID: 39823554
Background And Objectives: Antibodies to proteolipid protein-1 (PLP1-IgG), a major central myelin protein also expressed in the peripheral nervous system (PNS) as the isoform DM20, have been previously identified mostly...
2.
Schiro G, Gastaldi M, Iacono S, Scaranzin S, Picciolo V, Arnao V, et al.
Neurol Int . 2024 Dec; 16(6):1849-1855. PMID: 39728758
: Paraneoplastic neurological syndromes (PNSs) are rare conditions characterized by immune-mediated pathogenesis, frequently associated with the presence of a neoplasm. Although a single antineuronal antibody mediates a specific syndrome, atypical...
3.
Greco G, Risi M, Masciocchi S, Businaro P, Rigoni E, Zardini E, et al.
J Neurol Neurosurg Psychiatry . 2024 Jun; 95(12):1176-1186. PMID: 38844341
Background: Cerebrospinal fluid myelin oligodendrocyte glycoprotein IgG (CSF MOG-IgG) are found in a proportion of patients with MOG antibody-associated disorder (MOGAD) and have been associated with severe disease presentations. However,...
4.
Risi M, Greco G, Masciocchi S, Rigoni E, Colombo E, Businaro P, et al.
J Neurol . 2024 Jan; 271(5):2840-2843. PMID: 38280000
Background: Live cell-based assay (LCBA) is the gold standard for MOG-IgG detection, and fixed CBA (FCBA) is a widely used commercial alternative. Recent criteria attributed a diagnostic value to MOG-IgG...
5.
Masciocchi S, Businaro P, Scaranzin S, Morandi C, Franciotta D, Gastaldi M
Crit Rev Clin Lab Sci . 2023 Sep; 61(1):45-69. PMID: 37777038
Autoimmune encephalitis (AE) is a group of inflammatory conditions that can associate with the presence of antibodies directed to neuronal intracellular, or cell surface antigens. These disorders are increasingly recognized...
6.
Businaro P, Curro R, Vegezzi E, Diamanti L, Bini P, Cosentino G, et al.
Mult Scler Relat Disord . 2023 Jun; 76:104781. PMID: 37295322
Postinfectious neurological syndromes (PINS), among which acute disseminated encephalomyelitis (ADEM), are inflammatory and mostly monophasic disorders. We previously reported that PINS patients can show relapses, or even disease progression. Here...
7.
Bresciani L, Salvalaggio A, Vegezzi E, Visentin A, Fortuna A, Anglani M, et al.
J Peripher Nerv Syst . 2023 May; 28(3):522-527. PMID: 37246762
Aim: Nodopathies and paranodopathies are autoimmune neuropathies associated with antibodies to nodal-paranodal antigens (neurofascin 140/186 and 155, contactin-1, contactin-associated protein 1 [Caspr1]) characterized by peculiar clinical features, poor response to...
8.
Truffi M, Garofalo M, Ricciardi A, Ramusino M, Perini G, Scaranzin S, et al.
Sci Rep . 2023 Mar; 13(1):4041. PMID: 36899015
Neurofilament light chains (NfL) are neuron-specific cytoskeletal proteins whose plasmatic concentrations have been explored as a clinically useful marker in several types of dementia. Plasma concentrations of NfL are extremely...
9.
Gastaldi M, Foiadelli T, Greco G, Scaranzin S, Rigoni E, Masciocchi S, et al.
J Neurol Neurosurg Psychiatry . 2022 Dec; 94(3):201-210. PMID: 36460438
Background: IgG antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) define a subset of associated disorders (myelin oligodendrocyte glycoprotein associated disorders (MOGAD)) that can have a relapsing course. However, information on relapse...
10.
Spagni G, Gastaldi M, Businaro P, Chemkhi Z, Carrozza C, Mascagna G, et al.
Neurol Neuroimmunol Neuroinflamm . 2022 Oct; 10(1). PMID: 36270951
Background And Objectives: Live cell-based assay (CBA) can detect acetylcholine receptors (AChRs) or muscle-specific tyrosine kinase (MuSK) antibodies (Abs) in a proportion of patients with radioimmunoassay (RIA)-double seronegative myasthenia gravis...